Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Peglec Powder 137.15gm
Manufacturer/Marketed By : TABLETS INDIA LIMITED
$5.28 $4.49
Peglec Powder 137.15gm is a medication that combines polyethylene glycol 3350 and electrolytes. It cleanses the colon (bowel) and is prescribed for the treatment of constipation, which is characterized by...
ELECTROLYTES FOR ORAL SOLUTION,POLYETHYLENE GLYCOL 3350
Active Pharmaceutical Ingredient
Peglec Powder 137.15gm
$5.28
$4.49
Peglec Powder 137.15gm is a medication that combines polyethylene glycol 3350 and electrolytes. It cleanses the colon (bowel) and is prescribed for the treatment of constipation, which is characterized by infrequent bowel movements. Peglec powder for colonoscopy is widely used to prepare the bowel before procedures like colonoscopy and colorectal surgery. Do not consume Peglec Powder if you are allergic to electrolytes for oral solution, polyethylene glycol, or any of the ingredients in the medication. Before starting the treatment, inform your doctor if you have intestinal perforation or obstruction, severe inflammatory conditions of the intestinal tract like Crohn's disease and ulcerative colitis, and toxic megacolon. If you are on a salt-controlled diet, notify your doctor. Also, report any history of heart problems, electrolyte imbalances, kidney disease, seizures, gastroesophageal reflux disease (GERD), trouble swallowing, G6PD deficiency, or drug/alcohol addiction. Additionally, inform your doctor if you are pregnant, breastfeeding, or have phenylketonuria (increased phenylalanine level in the blood). If patients experience symptoms of fluid or electrolyte shifts (edema, shortness of breath, increasing fatigue, dehydration, cardiac failure), Peglec Powder 137.15gm should be stopped immediately. Electrolyte levels should be measured and treated as necessary. Before starting the medicine, patients with symptoms of bowel obstruction (nausea, vomiting, abdominal pain/distention) should be evaluated, and those with constipation should undergo a thorough examination to identify underlying causes. Always check the Peglec powder price before purchasing it, whether from an online store or a retail pharmacy.
Active Pharmaceutical Ingredient
Uses
• Treating constipation
• Bowel cleansing before medical procedures like colonoscopy and colorectal surgery
Benefits
Peglec Powder 137.15gm causes water retention in the stool, loosens the stools, and facilitates bowel movements. It helps you to have comfortable bowel movements even if you have been constipated for a long time. The composition of Peglec powder includes polyethylene glycol 3350, sodium chloride, sodium bicarbonate, and potassium chloride, making it highly effective for cleansing the bowel.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Most Common Side Effects
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Common Side Effects
• Bloating
• Stomach pain, discomfort
• Diarrhea
• Dizziness
• Less or no urination
• Seizure
• Signs of electrolyte imbalance (dry mouth, confusion, constipation, muscle pain or weakness)
How To Use
Take Peglec Powder 137.15gm as your physician advises. It is important to wait at least one hour after consuming solid food before drinking a polyethylene glycol electrolyte solution. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Safety Advice
• Breast Feeding: Peglec Powder 137.15gm should be cautiously taken during breastfeeding. Before starting the treatment, inform your doctor if you are breastfeeding. Contact your doctor for more information.
• Alcohol: Do not consume alcohol while taking Peglec Powder 137.15gm. Please speak with your physician.
• Liver: It is unknown whether Peglec Powder 137.15gm is safe for patients with liver problems. Inform your doctor if you have any liver disease before starting the treatment.
• Lungs: It is unknown whether Peglec Powder 137.15gm is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
• Driving: It is unknown whether Peglec Powder 137.15gm alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
• Pregnancy: It is unknown whether Peglec Powder 137.15gm is harmful to the unborn baby. Notify your healthcare professional if you are pregnant, planning to have a baby, or think you may be pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.



